In silico ADME/Pharmacokinetic and Target Prediction Studies of Ethambutol as Drug Molecule

The conventional approach for the development of any pharmaceutically active molecule is a time-consuming and costly process because the synthesis is followed by laboratory tests which are then followed by long clinical trials. Hence, a faster approach is desired. This article discusses Ethambutol, a frontline anti-tubercular drug that has its properties predicted by the SwissADME tool and the results would be compared with the findings published in the literature.

The main objective is to study the predicted and experimental ADME properties, compare them and study the predicted targets and understand the use of SwissADME for designing other drug molecules.

SwissADME, an online tool for ADME prediction, was used along with Swiss Target Prediction to understand the targets of the drug. Further, experimental data was obtained from the available scientific literature.

We found certain similarities between the predicted and experimental data. However, there were some variations, depending on the testing conditions. The results are interpreted ahead in the article.

Ethambutol's predicted ADME properties are discussed and as per findings from results, it can be concluded that other drug molecules can be similarly predicted using these tools. Also, based on predicted data, we can reformulate and prepare some different preparations of the drug.